Genetic polymorphisms of CCL2, CCL5, CCR2 and CCR5 genes in Sahariya tribe of North Central India: An association study with pulmonary tuberculosis

Infection, Genetics and Evolution

Volumn 12, Issue 5, 2012, Pages 1120-1127

  Mishra, Gunja ^a   Poojary, Satish S ^a   Raj, Prithvi ^a,b   Tiwari, Pramod Kumar ^a  

^a JIWAJI UNIVERSITY   (India)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Chemokines; Polymorphism; Resistance; Sahariya; Susceptibility; Tuberculosis

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ADULT; ALLELE; ARTICLE; BACTERIAL LOAD; CCL2 GENE; CCL5 GENE; CCR2 GENE; CCR5 GENE; CELL ACTIVATION; CELL SECRETION; CONTROLLED STUDY; DISEASE RESISTANCE; ETHNIC GROUP; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INDIA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; CHEMOKINE CCL2; CHEMOKINE CCL5; CHI-SQUARE DISTRIBUTION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INDIA; LINKAGE DISEQUILIBRIUM; MALE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CCR2; RECEPTORS, CCR5; TUBERCULOSIS, PULMONARY;

EID: 84860372767     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2012.03.018     Document Type: Article

References (34)

1. Ahad M.A., Missotten T., Abdallah A., Lympany P.A., Lightman S. Polymorphisms of chemokine and chemokine receptor genes in idiopathic immune-mediated posterior segment uveitis. Mol. Vis. 2007, 13:388-396.
2. Alagarasu K., Selvaraj P., Swaminathan S., Raghavan S., Narendran G., Narayanan P.R. CCR2, MCP-1, SDF-1α & DC-sign gene polymorphisms in HIV-1infected patients with and without tuberculosis. Indian J. Med. Res. 2009, 130:444-450.
3. Appay V., Rowland Jones S.L. RANTES: a versatile and controversial chemokine. Trends Immunol. 2001, 22:83-87.
4. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21(2):263-265.
5. Bonecchi R., Bianchi G., Bordignon P.P., D'Ambrosio D., Lang R., Borsatti A., Sozzani S., Allavena P., Gray P.A., Mantovani A., Sinigaglia F. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 1998, 187:129-134.
6. Buijtels P.C.A.M., van de Sande W.W.J., Parkinson S., Petit P.L.C., van de Sande M.A.B., van Soolingen D., Verbrugh H.A., van Belkum A. Polymorphism in CC-chemokine ligand 2 associated with tuberculosis in Zambia. Int. J. Tuberc. Lung Dis. 2008, 12(12):1485-1488.
7. Christopherson I.I.K., Hromas R. Chemokine regulation of normal and pathologic immune responses. Stem Cells 2001, 19:388-396.
8. Chu S.F., Tam C.M., Wong H.S., Kam K.M., Lau Y.L., Chiang A.K.S. Association between RANTES functional polymorphisms and tuberculosis in Hong Kong Chinese. Genes Immun. 2007, 8:475-479.
9. Fine P.E.M. Immunogenetics of susceptibility to leprosy, tuberculosis, and leishmaniasis: an epidemiological perspective. Int. J. Leprosy 1981, 49:437-454.
10. Flores-Villanueva P.O., Ruiz-Morales J.A., Song C.H., Flores M.L., Jo E.K., Montano M., Barnes P.F., Selman M., Granados J. A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis. J. Exp. Med. 2005, 202:1649-1658.
11. Frieden T.R., Sterling T.R., Munsiff S.S., Watt C.J., Dye C. Tuberculosis. Lancet 2003, 362:887-899.
12. Ginsberg A.M. A proposed national strategy for tuberculosis vaccine development. Clin. Infect. Dis. 2000, 30(Suppl. 3):S233-S242.
13. Jang Y., Chae J.S., Hyun Y.J., Koh S.J., Kim J.Y., Ko M.J., Rim S.J., Shin H.J., Ordovas J.M., Lee J.H. The RANTES -403G/A promoter polymorphism in Korean men: association with serum RANTES concentration and coronary artery disease. Clin. Sci. (Lond.) 2007, 113:349-356.
14. Kaur G., Singh P., Kumar N., Rapthap C.C., Sharma G., Vajpayee M., Wig N., Sharma S.K., Mehra N.K. Distribution of CCR2 polymorphism in HIV-1-infected and healthy subjects in north India. Int. J. Immunogenet. 2007, 34:153-156.
15. Lima, M.F., Zhang, Y., Villalta, F., 1997. Beta-chemokines that inhibit HIV-1 infection of human macrophages stimulate uptake and promote destruction of Trypanosoma cruzi by human macrophages. Cell. Mol. Biol. (Noisy-le-Grand) 43, 1067-1076.
16. Liu H., Chao D., Nakayama E.E., Taguchi H., Goto M., Xin X., Takamatsu J.K., Saito H., Ishikawa Y., Akaza T., Juji T., Takebe Y., Ohishi T., Fukutake K., Maruyama Y., Yashiki S., Sonoda S., Nakamura T., Naqai Y., Iwamoto A., Shioda T. Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc. Natl. Acad. Sci. USA 1999, 96:4581-4585.
17. Nakayama E.E., Tanaka Y., Nagai Y., Iwamoto A., Shioda T. A CCR2-V64I polymorphism affects stability of CCR2A isoform. AIDS 2004, 18:729-738.
18. Newport M.J., Blackwell J.M. Genetic susceptibility to tuberculosis. Baillier's Clin. Infect. Dis. Mycobact. Dis. 1997, 4:207-230.
19. Rajpal S., Dhingra V.K., Agarwal J.K. Sputum grading as predictor of treatment outcome in pulmonary tuberculosis. Indian J. Tuberc. 2002, 49:139.
20. Rathore A., Chatterjee A., Sivarama P., Yamamoto N., Dhole T.N. Role of homozygous DC-SIGNR 5/5 tandem repeat polymorphism in HIV-1 exposed seronegative north Indian individuals. J. Clin. Immunol. 2008, 28:50-57.
21. Sambrook, J., Russell, D.W., 2001. Preparation and analysis of eukaryotic genomic DNA. In: Sambrook, J., Russell, D.W. (Eds.), Molecular Cloning: A Laboratory Manual, third ed., vol 1. Cold Spring Harbor Laboratory Press, New York, pp. 6.1-6.12.
22. Sánchez-Castañón M., Baquero I.C., Sánchez-Velasco P., Farinas M.C., Ausin F., Leyva-Cobian F., Ocelo-Vinyals J.G. Polymorphisms in CCL5 promoter are associated with pulmonary tuberculosis in northern Spain. Int. J. Tuberc. Lung Dis. 2007, 13(4):480-485.
23. Selveraj P., Alagarasu K., Singh B., Afsal K. CCL5 (RANTES) gene polymorphisms in pulmonary tuberculosis patients of South India. Int. J. Immunogenet. 2011, 38(5):397-402.
24. Sharma P.R., Jain S., Tiwari P.K. Elevated level of serum LDH-2 and LDH-3 in sputum three positive TB patients of Sahariya tribe: a preliminary study. Clin. Biochem. 2007, 40:1414-1419.
25. Sharma P.R., Jain S., Bamezai R.N.K., Tiwari P.K. Increased prevalence of tuberculosis in male adults of Sahariya tribe of Central India: a revised survey. Ind. J. Commun. Med. 2010, 35(2):267-271.
26. Sharma P.R., Singh S., Jena M., Mishra G., Prakash R., Das P.K., Bamezai R.N.K., Tiwari P.K. Coding and non coding polymorphisms in VDR gene and susceptibility to tuberculosis in Tribes, Castes and Muslims of Central India. Infect. Genet. Evol. 2011, 11(6):1456-1461.
27. Siveke J.T., Hamann A. T helper 1 and T helper 2 cells respond differentially to chemokines. J. Immunol. 1998, 160:550-554.
28. Suresh P., Wanchu A., Sachdeva R.K., Bhatnagar A. Gene polymorphisms in CCR5, CCR2, CX3CR1, SDF-1 and RANTES in exposed but uninfected partners of HIV-1 infected individuals in North India. J. Clin. Immunol. 2006, 26:476-484.
29. Taub D.D., Turcovski-Corrales S.M., Key M.L., Longo D.L., Murphy W.J. Chemokines and T lymphocyte activation. I. Chemokines costimulate human T lymphocyte activation in vitro. J. Immunol. 1996, 156:2095-2103.
30. Thye T., Nejentsev S., Intemann C.D., Browne E.M., Chinbuah M.A., Gyapong J., Osei I., Owusu-Dabo E., Zeitels L.R., Herb F., Horstmann R.D., Meyer C.G. MCP-1 promoter variant 2362C associated with protection from pulmonary tuberculosis in Ghana, West Africa. Hum. Mol. Genet. 2009, 18(2):381-388.
31. Verma R., Gupta R.B., Singh K., Bhasin R., Shukla A.A., Chauhan S.S., Luthra K. Distribution of CCR5delta32, CCR2-64I and SDF1-3'A and plasma levels of SDF-1 in HIV-1 seronegative north Indians. J. Clin. Virol. 2007, 38:198-203.
32. Vesosky B., Rottinghaus E.K., Stromberg P., Turner J., Beamer G. CCL5 participates in early protection against Mycobacterium tuberculosis. J. Leukoc. Biol. 2010, 87:1153-1165.
33. World Health Organization, 2011. Global Tuberculosis Control. WHO Report.
34. Ye D.Q., Hu Y.S., Li X.P., Yang S.G., Hao J.H., Huang F., Zhang X.J. The correlation between monocyte chemoattractant protein-1and the arthritis of systemic lupus erythematosus among Chinese. Arch. Dermatol. Res. 2005, 296:366-371.